Steps and time to process clinical trials at the cancer therapy evaluation program

Journal of Clinical Oncology

Volumn 27, Issue 11, 2009, Pages 1761-1766

  Crites, Joshua S ^a   Dilts, David M ^a   Sandler, Alan B ^a   Cheng, Steven K ^a   Ferranti, Lori B ^a   Wu, Amy Y ^a   Finnigan, Shanda ^a   Friedman, Steven ^a   Mooney, Margaret ^a   Abrams, Jeffrey ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RESEARCH; CANCER THERAPY; CLINICAL RESEARCH; MEDICAL LITERATURE; NATIONAL HEALTH ORGANIZATION; PEER GROUP; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PUBLICATION; QUALITY CONTROL;

CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; NATIONAL CANCER INSTITUTE (U.S.); RESEARCH DESIGN; TIME FACTORS; UNITED STATES;

EID: 64649092129     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.9133     Document Type: Article

References (14)

1. Lara PN Jr, Higdon R, Lim N, et al: Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 19:1728-1733, 2001
2. Comis RL, Miller JD, Aldige CR, et al: Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21:830-835, 2003
3. Dilts DM, Sandler AB: Invisible barriers to clinical trials: The impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol 24:4545-4552, 2006
4. Dilts DM, Sandler AB, Baker M, et al: Processes to activate phase III clinical trials in a Cooperative Oncology Group: The Case of Cancer and Leukemia Group B. J Clin Oncol 24:4553-4557, 2006
5. Dilts DM, Sandler A, Cheng S, et al: Development of clinical trials in a cooperative group setting: The Eastern Cooperative Oncology Group. Clin Cancer Res 14:3427-3433, 2008
6. National Cancer Institute: Report of the Clinical Trials Working Group of the National Cancer Advisory Board: Restructuring the National Cancer Clinical Trials Enterprise. http://spores.nci.nih.gov/publicActwg-finrpt-June2005.pdf
7. National Cancer Institute: Cancer Therapy Evaluation Program. http://ctep.cancer.gov
8. National Cancer Institute: The Central Institutional Review Board Initiative. http://www.ncicirb.org
9. National Cancer Institute: Cancer Therapy Evaluation Program: The Mission of the Cancer Therapy Evaluation Program. http://ctep.cancer.gov/about/default. htm
10. Ansher SS, Scharf R: The Cancer Therapy Evaluation Program (CTEP) at the National Cancer Institute: Industry Collaborations in New Agent Development. Ann N Y Acad Sci 949:333-340, 2001
11. National Cancer Institute: Division of Cancer Treatment and Diagnosis. http://dctd.cancer.gov/ProgramPages/CTEP.htm
12. Christian MC, McCabe MS, Korn EL, et al: The National Cancer Institute Audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med 333:1469-1474, 1995
13. Center for Management Research in Healthcare: Process Maps. http://www.cmrhc.org/processmaps.html
14. Mello MM, Clarridge BR, Studdert DM: Academic medical centers' standards for clinical-trial agreements with industry. N Engl J Med 352:2202-2210, 2005